Published October 2017 | Version v1
Journal article

Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography

  • 1. German Cancer Research Center (dkfz), Department of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)
  • 2. German Cancer Research Center (dkfz), Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)
  • 3. Radiological Clinic at the ATOS Clinic Heidelberg, Bismarckplatz 9-15, 69123 Heidelberg (Germany)
  • 4. Radiology Center Mannheim (RZM), Rosengartenplatz 7, 61818 Mannheim (Germany)
  • 5. University Hospital Heidelberg, Department of Clinical and Interventional Radiology, Im Neuenheimer Feld 400, 69120 Heidelberg (Germany)
  • 6. German Cancer Research Center (dkfz), Department of Biostatistics, Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)

Description

Aim: To investigate an abbreviated, contrast-agent free diffusion-weighted (DW) breast magnetic resonance imaging (MRI) protocol that provides a single image for the radiologist to read in order to non-invasively examine Breast Imaging-Reporting and Data System (BI-RADS) 4 lesions detected using breast cancer screening X-ray mammography. Materials and methods: This retrospective evaluation within a institutional review board-approved, prospective study included 115 women (mean 57 years, range 50–69 years) with BI-RADS 4 findings on X-ray mammography and indication for biopsy over a period of 15 months. Full diagnostic breast MRI (FDP) was performed prior to biopsy (1.5 T). Maximum intensity breast diffusion (MIBD) images were generated from DW images (b = 1,500 mm/s2, 3 mm section thickness) of the breast. MIBD and T2-weighted (T2W) images were read by two radiologists and compared to the diagnostic accuracy of an expert reading of the FDP with histopathology as the reference standard. The acquisition time of MIBD and T2W MRI was about 7 minutes. Results: MIBD MRI provided a diagnostic accuracy of 87.93% (95% confidence interval [CI]: 80.58–93.24%) for R1 and 89.66% (95% CI: 82.63–94.54%) for R2. Expert reading of the FDP revealed a similar accuracy of 86.2% (95% CI: 78.67–91.43%). The positive predictive value (PPV) could be increased from 36.2% (95% CI: 28.02–45.28; X-ray mammography alone) to a mean PPV of 80.89% (R1 79.17%, R2 82.16%) using MIBD MRI. Mean reading time was 30 seconds (25%/75 percentile 24.5–41.25). Conclusions: MIBD MRI might be of supplemental value if added to the work-up of BI-RADS 4 X-ray mammography screening findings. MIBD MRI might help reduce the false-positive rate prior to biopsy for reference lesions at only limited expense of measurement and reading time. - Highlights: • MIBDI-MRI can help to non-invasively characterize BI-RADS 4 X-ray mammography lesions. • MIBDI-MRI only needs limited measurement and reading time. • MIBDI-MRI increased the positive predictive value (PPV) from 36.2% to 80.89%. • Radiologist mean reading time for MIBDI-MRI was about 30 seconds per patient.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.crad.2017.05.017

Additional details

Identifiers

DOI
10.1016/j.crad.2017.05.017;
PII
S0009-9260(17)30209-X;

Publishing Information

Journal Title
Clinical Radiology
Journal Volume
72
Journal Issue
10
Journal Page Range
p. 900.e1-900.e8
ISSN
0009-9260
CODEN
CLRAAG

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49087645
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOMEDICAL RADIOGRAPHY; BIOPSY; CONTRAST MEDIA; MAMMARY GLANDS; NMR IMAGING; X RADIATION
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; ELECTROMAGNETIC RADIATION; GLANDS; IONIZING RADIATIONS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIATIONS; RADIOLOGY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.